Mild-to-moderate functional tricuspid regurgitation in patients undergoing valve replacement for rheumatic mitral disease: the influence of tricuspid valve repair on clinical and echocardiographic outcomes

BackgroundThe decision to repair mild-to-moderate functional tricuspid regurgitation (TR) during left-side heart surgery remains controversial.ObjectivesTo avoid heterogeneity in patient population, patients with TR undergoing isolated mechanical mitral valve (MV) replacement for rheumatic mitral di...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart (British Cardiac Society) 2012-01, Vol.98 (1), p.24-30
Hauptverfasser: Kim, Joon Bum, Yoo, Dong Gon, Kim, Gwan Sic, Song, Hyun, Jung, Sung-Ho, Choo, Suk Jung, Chung, Cheol Hyun, Lee, Jae Won
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundThe decision to repair mild-to-moderate functional tricuspid regurgitation (TR) during left-side heart surgery remains controversial.ObjectivesTo avoid heterogeneity in patient population, patients with TR undergoing isolated mechanical mitral valve (MV) replacement for rheumatic mitral diseases were evaluated.MethodsBetween 1997 and 2009, 236 patients with mild-to-moderate functional TR underwent first-time isolated mechanical MV replacement for rheumatic mitral diseases with (n=123; repair group) or without (n=113; non-repair group) tricuspid valve (TV) repair. Survival, valve-related complications, and TV function in these two groups were compared after adjustment for baseline characteristics using inverse-probability-of-treatment weighting.ResultsFollow-up was complete in 225 patients (95.3%) with a median follow-up of 48.7 months (IQR 20.2–89.5 months), during which time 991 echocardiographic assessments were done. Freedom from moderate-to-severe TR at 5 years was 92.9±2.9% in the repair group and 60.8±6.9% in the non-repair group (p
ISSN:1355-6037
1468-201X
DOI:10.1136/heartjnl-2011-300403